multipl
sclerosi
ms
inflammatoryneurodegen
diseas
central
nervou
system
cn
genet
environment
factor
cooper
chronic
activ
immun
cell
produc
oligodendrocyt
neuron
damag
epidemiolog
studi
identifi
sever
environment
risk
factor
ms
exposur
certain
virus
smoke
even
lack
exposur
sunlight
subsequ
reduc
vitamin
product
factor
associ
suscept
develop
ms
could
also
influenc
diseas
cours
howev
singl
risk
factor
per
se
appear
respons
develop
diseas
multifactori
interplay
like
complex
interplay
quit
difficult
defin
real
impact
singl
factor
respect
way
proceed
design
larg
enough
studi
highqual
data
howev
certainli
even
less
known
way
extern
factor
abl
induc
sustain
intern
patholog
process
diseas
chapter
tri
provid
overview
relev
environment
factor
may
affect
immun
respons
ms
though
etiolog
ms
remain
yet
unknown
pathogenesi
quit
extens
investig
mostli
clarifi
sinc
wide
accept
activ
peripher
immun
cell
enter
cn
produc
patholog
initi
dysfunct
also
occur
within
cn
includ
mitochondri
dysfunct
neuron
oligodendrocyt
axon
energi
insuffici
even
damag
neural
organel
peroxisom
case
whichev
initi
injuri
leakag
cn
antigen
drain
lymph
node
activ
cell
address
enter
cn
induc
inflamm
demyelin
oligodendrocyt
loss
well
axonalneuron
injuri
loss
profession
antigenpres
cell
apc
dendrit
cell
need
activ
cell
apc
either
peripheri
cn
migrat
lymph
node
carri
antigen
short
segment
pathogen
bound
major
histocompat
complex
mhc
class
ii
commit
cell
surfac
lymph
node
antigen
present
cell
tcell
receptor
tcr
recogn
antigenmhc
combin
trimolecular
complex
mhcantigentcr
constitut
first
signal
second
signal
mediat
costimulatori
molecul
eg
apc
cell
need
full
activ
cell
prolifer
subsequ
differenti
effector
cell
cell
crucial
ms
differenti
proinflammatori
helper
th
subset
antiinflammatori
cell
cell
regulatoryantiinflammatori
properti
treg
depend
microenviron
cytokin
milieu
ms
patient
tendenc
gener
either
subset
addit
proinflammatori
may
neurotox
effect
wherea
regulatoryantiinflammatori
treg
subset
report
defici
ms
cell
also
relev
role
ms
tissu
damag
b
cell
also
importantli
produc
diseas
patholog
ms
support
variou
evid
includ
effect
monoclon
antibodi
therapi
target
bcell
antigen
ii
pathomechan
oligoclon
band
cerebrospin
fluid
commonli
report
ms
patient
bcell
follicularlik
structur
found
mening
secondari
progress
ms
patient
addit
pathogenet
role
product
antibodi
target
cn
structur
b
cell
may
play
addit
role
antigen
present
help
cell
activ
immun
cell
upregul
differ
adhes
molecul
adher
endotheli
cell
postcapillari
venul
cn
cross
endotheli
cell
barrier
mean
proteolyt
activ
matrix
metalloproteinas
mmp
first
migrat
across
endotheli
basement
membran
parenchym
basement
membran
glia
limitan
final
enter
cn
parenchyma
matter
fact
mmp
report
upregul
ms
upon
enter
cn
parenchyma
cell
reactiv
repeat
antigen
present
apc
microglia
macrophag
b
cell
dendrit
cell
activ
immun
cell
subset
well
inflamm
demyelin
also
induc
neuron
injuri
loss
produc
free
radic
glutam
excitotoxin
proteas
cytokin
therefor
quit
evid
ms
characterist
inflammatorydemyelin
neurodegen
diseas
term
patholog
also
clear
term
clinic
present
cours
accumul
disabl
patient
even
inherit
disord
genet
factor
certainli
implic
diseas
suscept
especi
evid
studi
demonstr
increas
risk
ms
rel
patient
ms
higher
risk
closer
individu
relat
patient
sever
genet
loci
chromosom
report
associ
increas
risk
ms
nevertheless
effort
focus
epigenet
mechan
may
influenc
pathophysiolog
ms
epigenet
studi
mechan
alter
express
gene
without
alter
dna
sequenc
dna
methyl
histon
modif
microrna
mirna
associ
posttranscript
gene
silenc
three
investig
epigenet
mechan
even
epigenet
chang
pass
parent
offspr
germ
line
highli
sensit
environment
factor
therefor
may
realli
influenc
suscept
diseas
act
epigenet
modif
dna
methyl
consist
addit
methyl
group
cytosin
residu
dna
intervent
enzym
call
dna
methyltransferas
dnmt
maintain
dna
methyl
pattern
dna
replic
local
dna
replic
fork
methyl
nascent
dna
strand
locat
templat
strand
interven
de
novo
methyl
unmethyl
hemimethyl
site
nuclear
mitochondri
dna
respect
especi
mammal
dna
methyl
usual
occur
cpg
site
cytosin
nucleotid
follow
guanin
nucleotid
found
sever
hundr
dinucleotid
repeat
therefor
call
cpg
island
mostli
found
gene
promot
region
methyl
hypermethyl
cpg
island
promot
region
report
block
express
associ
gene
dna
methyl
best
investig
physiolog
epigenet
mechan
far
mainli
mammalian
cell
histon
protein
interact
dna
form
chromatin
packag
form
dna
histon
octam
consist
two
copi
four
histon
protein
histon
octam
bp
dna
strand
wrap
around
shape
one
nucleosom
basic
unit
chromatin
histon
protein
modifi
posttransl
chang
acetyl
methyl
phosphoryl
ubiquitin
citrullin
sinc
histon
modif
produc
chang
structur
chromatin
may
affect
access
dna
strand
transcript
enzym
therefor
induc
either
activ
repress
gene
associ
modifi
histon
acetyl
mediat
histon
acetyltransferas
deacetylas
current
investig
henc
clarifi
histon
modif
acetyl
histon
gener
result
upregul
transcript
activ
associ
gene
wherea
deacetyl
histon
contribut
transcript
silenc
singlestrand
noncod
mirna
wide
repres
cell
either
plant
anim
transcript
undergo
sever
posttransl
chang
either
nucleu
cytoplasm
gener
matur
function
mirna
moreov
cytoplasm
matur
mirna
associ
protein
form
rnainduc
silenc
complex
risc
mirna
imperfectli
pair
cognat
mrna
transcript
target
mrna
degrad
risc
prevent
translat
protein
mirnamedi
repress
translat
util
mani
cellular
process
name
differenti
prolifer
apoptosi
well
key
cellular
mechan
current
knowledg
role
epigenet
mechan
ms
mostli
come
patholog
studi
either
biopsi
autopsi
focus
activ
demyelin
chronic
lesion
also
studi
patient
ms
either
relapsingremit
rr
chronic
primari
progress
pp
secondaryprogress
sp
cours
patient
brain
biopsi
sampl
show
activ
inact
ms
lesion
distinct
mirna
profil
matter
fact
mirna
highli
upregul
activ
ms
lesion
compar
inact
lesion
normal
white
matter
healthi
control
differenti
cell
especi
cell
influenc
epigenet
mechan
also
associ
tcell
differenti
express
upregul
macrophag
cell
b
cell
respons
ligand
bind
tolllik
receptor
tlr
inflammatori
cytokin
suggest
involv
inflammatori
process
mice
defici
highli
resist
develop
experiment
autoimmun
encephalomyel
eae
anim
model
ms
silenc
administ
antisens
oligonucleotid
induct
eae
attenu
sever
symptom
moreov
express
upregul
mice
eae
vivo
silenc
mirna
result
attenu
eae
symptom
reduc
number
cell
other
shown
untreat
ms
ppm
spm
rrm
healthi
control
two
mirna
downregul
three
form
ms
two
mirna
inhibit
tcell
activ
downregul
patient
ms
therefor
might
contribut
net
increas
tcell
differenti
includ
differenti
cell
especi
progress
ms
evid
involv
epigenet
chang
come
studi
show
associ
dna
methyl
neuron
cell
death
fact
overexpress
enzym
involv
de
novo
dna
methyl
induc
apoptosi
far
histon
modif
concern
citrullin
myelin
basic
protein
mbp
import
role
pathophysiolog
ms
mbp
major
compon
myelin
cn
modifi
sever
way
translat
biopsi
sampl
ms
patient
normalappear
white
matter
show
increas
level
citrullin
mbp
compar
level
healthi
control
patient
alzheim
diseas
citrullin
mbp
less
stabl
unmodifi
mbp
suggest
citrullin
might
contribut
myelin
breakdown
eventu
develop
autoimmun
respons
mbp
final
brain
biopsi
materi
progress
ms
patient
control
without
neurolog
diseas
show
increas
histon
acetyl
oligodendrocyt
within
chronic
ms
lesion
wherea
oligodendrocyt
within
earlystag
ms
lesion
show
mark
histon
deacetyl
increas
histon
acetyl
oligodendrocyt
associ
impair
differenti
therefor
impair
remyelin
sinc
epigenet
chang
highli
sensit
environment
influenc
like
effect
environment
risk
factor
ms
might
mediat
chang
patient
epigenet
profil
migrat
studi
contribut
provid
evid
viral
infect
may
trigger
develop
ms
shown
peopl
migrat
highrisk
countri
ms
lowrisk
one
lower
risk
develop
ms
would
countri
origin
wherea
migrat
lowrisk
countri
highrisk
one
keep
low
risk
countri
origin
children
risk
compar
countri
emigr
especi
migrat
age
suggest
infect
young
age
may
predispos
later
develop
ms
addit
migrat
studi
classic
studi
incid
preval
ms
suggest
may
ms
epidem
sever
locat
faro
island
ii
pathomechan
second
world
war
increas
incid
shetland
island
sardinia
taken
suggest
infecti
agent
may
involv
pathogenesi
ms
differ
hypothes
propos
explain
viral
infect
associ
ms
accord
bystand
activ
hypothesi
autoreact
cell
activ
nonspecif
inflammatori
molecul
occur
infect
cytokin
superantigen
tlr
ligand
molecular
mimicri
hypothesi
instead
postul
upon
exposur
pathogen
pathogenmhc
conform
apc
bear
molecular
similar
endogen
peptid
mbp
fragment
present
within
mhc
appropri
costimul
occur
result
expans
differenti
pathogenreact
cell
proper
immun
respons
also
expans
mbpreactiv
cell
improp
respons
pool
differenti
proinflammatori
subset
becom
reactiv
within
cn
promot
patholog
fact
tcell
line
isol
ms
patient
demonstr
crossreact
mbp
coronaviru
epsteinbarr
viru
ebv
antigen
furthermor
signific
degre
crystal
structur
similar
shown
peptid
complex
peptid
complex
cell
surfac
tcr
recognit
immunolog
evid
associ
ebv
ms
provid
follicularlik
structur
mening
includ
b
cell
infect
ebv
mani
patient
ms
patient
antibodi
crossreact
mbp
ebv
possibl
addit
mechan
antiebv
antibodi
may
disrupt
myelin
furthermor
ebvreact
cell
restrict
common
allel
ms
dysregul
ms
tcell
defici
ms
impair
capac
control
ebv
infect
result
ebvinfect
b
cell
accumul
cn
produc
pathogen
autoantibodi
provid
surviv
signal
autoreact
cell
ebv
infect
certainli
associ
chang
epigenet
profil
infect
cell
far
evalu
especi
tumor
result
sever
type
tumor
associ
prior
ebv
infect
probabl
due
promot
hypermethyl
therefor
repress
tumor
suppressor
gene
still
lack
evid
aspect
ms
despit
molecular
similar
sever
pathogen
number
myelin
peptid
molecul
within
cn
frequent
occur
high
probabl
pathogen
induc
improp
expans
cnsreactiv
cell
promot
patholog
within
cn
henc
singl
infecti
agent
may
uniqu
associ
ms
epidemiolog
clinic
studi
recogn
smoke
environment
risk
factor
ms
smoke
increas
rel
incid
rate
ms
current
smoker
compar
nonsmok
doserespons
depend
number
pack
smoke
per
year
smoke
also
impact
inflammatori
outcom
ms
patient
clinic
isol
syndrom
increas
risk
convers
clinic
definit
ms
smoker
compar
nonsmok
ms
smoker
gadoliniumenhanc
lesion
greater
load
brain
atrophi
nonsmok
well
quicker
ii
pathomechan
increas
volum
brain
atrophi
averag
followup
period
time
far
diseas
progress
concern
data
quit
discord
sinc
smoke
case
report
associ
risk
sp
reach
expand
disabl
statu
scale
edss
other
report
associ
greater
risk
sp
cours
even
increas
edss
score
two
year
followup
conclus
smoke
may
influenc
earli
diseas
cours
late
diseas
stage
ms
smoke
increas
risk
ms
still
matter
debat
even
whether
cigarett
smoke
contain
mutagen
affect
longlast
immun
smoke
demonstr
induc
immunosuppress
state
nevertheless
cigarett
smoke
induc
immun
function
interact
smoke
gene
regul
immun
function
report
would
relev
figur
whether
constitu
tobacco
alter
signal
aryl
hydrocarbon
receptor
transcript
factor
affect
polycycl
aromat
hydrocarbon
polychlorin
dioxin
sinc
latter
regul
tcell
polar
alter
cours
eae
almost
certain
smoke
affect
ms
upregul
mmp
sinc
immun
cell
biolog
fluid
smoker
tend
upregul
sever
mmp
may
facilit
immunecel
entri
cn
parenchyma
compar
mri
scan
smoker
nonsmok
ms
contrastenhanc
lesion
evid
among
smoker
suggest
sever
bloodbrain
barrier
damag
smoke
far
report
associ
chang
epigenet
profil
patient
cancer
especi
induc
silenc
tumor
suppressor
gene
mostli
dna
methyl
smoke
also
associ
chang
mirna
express
profil
spermatozoa
alter
histon
modif
result
reduc
level
histon
deacetylas
macrophag
ms
evid
respect
doubt
mechan
worth
investig
diseas
ms
preval
region
higher
latitud
increas
femalemal
rate
incid
also
demonstr
phenomenon
seem
associ
decreas
sunlight
uv
exposur
subsequ
reduc
vitamin
product
shown
risk
develop
ms
decreas
increas
serum
level
prospect
casecontrol
studi
among
variou
suspect
environment
factor
ms
lack
uv
exposur
found
signific
risk
factor
ms
moreov
vitamin
may
influenc
diseas
cours
ms
sinc
lower
vitamin
level
demonstr
associ
higher
level
disabl
associ
higher
level
vitamin
decreas
risk
relaps
also
report
final
author
provid
data
show
vitamin
supplement
may
effect
treatment
ms
sinc
highdos
vitamin
treatment
ms
tend
decreas
relaps
possibl
sequenc
event
link
sunlight
exposur
ms
like
base
convers
due
ultraviolet
b
radiat
nm
cutan
previtamin
spontan
give
origin
vitamin
latter
undergo
two
hydroxyl
liver
ii
pathomechan
kidney
produc
biolog
activ
form
vitamin
variant
gene
report
associ
increas
risk
ms
other
confirm
associ
ms
two
vitamin
drelat
gene
vitamin
respons
element
lie
close
promot
region
main
risk
allel
ms
differ
mechan
action
vitamin
may
impact
differ
step
diseas
immunopathogenesi
report
vitamin
either
suppress
matur
activ
apc
includ
dendrit
cell
increas
tolerogen
phenotyp
helper
cell
also
affect
vitamin
reduc
product
proinflammatori
cell
cell
increas
vitamin
treatment
induc
treg
activ
reduc
proinflammatori
molecul
produc
stimul
monocyt
eae
vitamin
prove
effect
either
given
prevent
therapeut
treatment
vitamin
enter
cn
exert
immuneregul
properti
possibl
neuroprotect
role
uncertain
certainli
enzym
necessari
synthes
bioactiv
present
brain
abnorm
brain
develop
observ
rat
defici
vitamin
gestat
moreov
mice
gestat
vitamin
defici
impair
learn
adulthood
vitro
vitamin
abl
reduc
glutam
excitotox
cortic
cerebellar
hippocamp
neuron
whether
vitamin
neuroprotect
experiment
evid
valid
human
ms
still
remain
elucid
final
quit
evid
vitamin
may
correct
mani
immun
abnorm
seen
ms
nevertheless
mechan
relev
therapeut
efficaci
whether
mechan
includ
action
within
cn
yet
unclear
evid
also
exist
suggest
vitamin
might
influenc
epigenet
mechan
report
affect
histon
modif
cancer
studi
human
colon
cancer
cell
shown
vitamin
induc
express
gene
encod
lysinespecif
demethylas
specif
demethyl
lysin
histon
far
ms
concern
potenti
relev
vitamin
dinduc
histon
modif
suggest
studi
show
bind
vitamin
receptor
lead
suppress
transcript
proinflammatori
cytokin
via
recruit
histon
deacetylas
promot
region
despit
infect
agent
long
investig
possibl
trigger
autoimmun
ms
involv
still
remain
matter
debat
studi
focus
involv
resid
commens
microbiota
cn
autoimmun
human
colon
myriad
microb
includ
bacteria
archaea
fungi
eukaryot
virus
mucos
surfac
skin
collect
term
microbiota
microbi
organ
mostli
belong
two
larg
phyla
bacteroidet
firmicut
microbiota
may
gener
benefici
function
host
may
influenc
physiolog
andor
patholog
host
studi
eae
clarifi
microbi
flora
contribut
cnsspecif
autoimmun
diseas
fact
spontan
eae
incid
found
strongli
ii
pathomechan
reduc
tcr
transgen
mice
kept
germfre
gf
condit
therefor
resid
microb
eae
sever
also
reduc
gf
mice
immun
myelin
peptid
antigen
complet
freund
adjuv
moreov
antibiot
found
affect
diseas
sever
alter
gut
flora
nevertheless
remain
unclear
agent
may
becom
detriment
sinc
microbiota
impact
host
immun
system
like
shift
balanc
protect
pathogen
immun
respons
inde
antibioticmedi
protect
eae
associ
decreas
product
proinflammatori
cytokin
gutassoci
lymphoid
tissu
thu
alter
function
invari
naturalkil
cell
also
increas
treg
cnsreactiv
immun
cell
activ
commens
microbiota
either
molecular
mimicri
bystand
activ
mechan
propos
infecti
pathogen
howev
far
cnsmimicri
epitop
deriv
gut
bacteria
identifi
wherea
current
data
provid
evid
favor
bystand
activ
hypothesi
like
cell
gener
gut
result
bystand
activ
apc
secret
cytokin
drive
cell
toward
proinflammatori
phenotyp
nevertheless
report
specif
commens
microbi
speci
may
induc
either
treg
cell
intestin
well
peripher
site
far
clear
evid
support
involv
gut
microbiota
either
incid
pathogenesi
ms
howev
indirect
data
suggest
potenti
implic
especi
consid
dietari
factor
rapidli
alter
gut
microbi
signatur
time
write
pathophysiolog
mechan
mediat
effect
environment
risk
factor
suscept
ms
cours
diseas
still
unknown
quit
intrigu
though
import
environment
risk
factor
ms
seem
clearli
associ
chang
epigenet
profil
research
certainli
requir
establish
whether
epigenet
mechan
truli
mediat
effect
risk
factor
final
microbiota
also
deserv
taken
consider
extern
factor
favor
diseas
given
relev
implic
control
host
immun
system
